Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Lineage Cell Therapeutics (LCTX) stocks
Learn how to easily invest in Lineage Cell Therapeutics stocks.
Lineage Cell Therapeutics is a biotechnology business based in the US. Lineage Cell Therapeutics stocks (LCTX.US) are listed on the NYSE MKT and all prices are listed in US Dollars. Its last market close was $2.89 – a decrease of 2.27% over the previous week. Lineage Cell Therapeutics employs 70 staff and has a trailing 12-month revenue of around $11.9 million.
How to buy Lineage Cell Therapeutics stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – LCTX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
National Bank Direct Brokerage
- Commission-free trading
- Several account types available
- Access to array of research tools
CIBC Investor's Edge
- Easy to use platform
- Low fees
- Student and young investor discounts
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
What's in this guide?
- Can I buy shares in Lineage Cell Therapeutics?
- Has coronavirus impacted Lineage Cell Therapeutics shares?
- Lineage Cell Therapeutics shares summary
- Compare share dealing platforms
- Is Lineage Cell Therapeutics stock a buy or sell?
- Lineage Cell Therapeutics performance over time
- Lineage Cell Therapeutics's financials
- How volatile are Lineage Cell Therapeutics shares?
- Does Lineage Cell Therapeutics pay a dividend?
- Have Lineage Cell Therapeutics shares ever split?
- Other common questions
Lineage Cell Therapeutics stock price (NYSE MKT:LCTX)Use our graph to track the performance of LCTX stocks over time.
Lineage Cell Therapeutics shares at a glance
|Latest market close||$1.29|
|52-week range||$1.02 - $1.79|
|50-day moving average||$1.39|
|200-day moving average||$1.34|
|Wall St. target price||$5.50|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.14|
Buy Lineage Cell Therapeutics stocks from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Lineage Cell Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Lineage Cell Therapeutics price performance over time
Historical closes compared with the close of $1.29 from 2023-05-26
|1 week (2023-05-23)||-2.27%|
|1 month (2023-04-28)||-5.15%|
|3 months (2023-03-02)||-7.19%|
|6 months (2022-11-30)||-11.03%|
|1 year (2022-05-27)||-1.53%|
|2 years (2021-05-28)||-45.57%|
|3 years (2020-05-29)||46.59%|
|5 years (2018-05-30)||2.22|
Lineage Cell Therapeutics financials
|Revenue TTM||$11.9 million|
|Gross profit TTM||$14 million|
|Return on assets TTM||-9.33%|
|Return on equity TTM||-30.69%|
|Market capitalisation||$219.5 million|
TTM: trailing 12 months
Lineage Cell Therapeutics share dividends
We're not expecting Lineage Cell Therapeutics to pay a dividend over the next 12 months.
Have Lineage Cell Therapeutics's shares ever split?
Lineage Cell Therapeutics's shares were split on a 3:1 basis on 31 October 1997. So if you had owned 1 share the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Lineage Cell Therapeutics shares – just the quantity. However, indirectly, the new 66.7% lower share price could have impacted the market appetite for Lineage Cell Therapeutics shares which in turn could have impacted Lineage Cell Therapeutics's share price.
Lineage Cell Therapeutics share price volatility
Over the last 12 months, Lineage Cell Therapeutics's shares have ranged in value from as little as $1.02 up to $1.79. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Lineage Cell Therapeutics's is 1.6791. This would suggest that Lineage Cell Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Lineage Cell Therapeutics overview
Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, an allogeneic retinal pigment epithelium cell replacement therapy, which is in Phase 2a clinical trial for the treatment of the dry age-related macular degeneration; OPC1, an allogeneic oligodendrocyte progenitor cell therapy that is in Phase 1/2a multicenter clinical trial for the treatment of cervical spinal cord injuries; and VAC2, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells, which is in Phase I clinical trial to treat non-small cell lung cancer. It also offers ANP1, an allogeneic auditory neuron progenitor cell transplant, which is in preclinical development for the treatment of debilitating hearing loss; and PNC1, an allogeneic photoreceptor cell transplant, which is in preclinical development for the treatment of vision loss due to photoreceptor dysfunction or damage. In addition, the company engages in the research and development of therapeutic products for retinal diseases, neurological diseases, and disorders and oncology. Lineage Cell Therapeutics, Inc. has a collaboration with Immunomic Therapeutics, Inc.
Stocks similar to Lineage Cell Therapeutics
Lineage Cell Therapeutics in the news
Lineage Cell Therapeutics Expected to Be Added to Russell 3000® Index
Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q1 2023 Earnings Call Transcript
Lineage Cell (LCTX) Reports Q1 Loss, Lags Revenue Estimates
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.Read more…
Best stock app for beginners for 2023
The best stock trading app for beginners is easy to use and offers free trades.Read more…
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.Read more…
More guides on Finder
Guide to finding the best prepaid card in Canada in May 2023
We show you the best prepaid credit cards in Canada, whether you’re looking for a prepaid card with no fees, cash back rewards, or travel perks, or more.
How to buy Sui (SUI) in Canada
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
5 apps like Nyble in Canada
Compare apps like Nyble in Canada to access emergency funding.
Your guide to buying and financing a car in Canada with RightRide.
Compare bad credit car loans in BC
Your guide to bad credit car loans in BC and how to find the right financing for your needs.
Camera financing in Canada
Compare six ways to finance a camera in Canada, including options for good and bad credit.
How to buy Pepe (PEPE) in Canada
This guide provides step-by-step instructions on how to buy Pepe, lists some exchanges where you can get it and provides daily price data on (PEPE).
Personal loans in Saskatchewan up to $50,000
Compare lenders to find the best personal loan in Saskatchewan for your needs.
Compare bad credit loans in Winnipeg
Compare interest rates and eligibility requirements of bad credit loans in Winnipeg.
Money Management for Teens: 7 Tips from Financial Experts
Teaching teenagers how to budget can be a tricky task. 7 experts give their best tips on how to budget for teenagers.